openPR Logo
Press release

Smart Compound Stewardship for DMPK: WuXi AppTec DMPK's Automated Compound Management with Full-Process Traceability

07-03-2026 11:46 AM CET | Health & Medicine

Press release from: WuXi AppTec

Smart Compound Stewardship for DMPK: WuXi AppTec DMPK's

Leveraging over 15 years of laboratory operational expertise, WuXi AppTec (https://www.wuxiapptec.com/) DMPK has provided compound management services to thousands of pharmaceutical and biotechnology companies worldwide, supporting a storage capacity of over one million compounds. The platform enables "full lifecycle compound management" through digital intelligent operations, ensuring end-to-end visibility and traceability from receipt to disposal to minimize human error. Core capabilities include automated robotic retrieval under various storage conditions, real-time integration of weighing data with high-precision balances, and automated separation and preparation via Hamilton systems-ensuring compounds are pre-prepared to significantly reduce wait times and accelerate project turnaround. Furthermore, the solution integrates real-time logistics tracking, image recognition-based automated picking, high-density mobile storage, and tamper-proof audit logs, seamlessly interfacing with the Mosaic Compound Management System to create a secure and transparent intelligent management loop.

Meanwhile, we have established a standardized cross-border compliance framework offering efficient import and export services, featuring full-process visualization and early regulatory intervention support for global markets, thereby significantly reducing logistical delays and compliance risks in international R&D collaborations.
Why does rigorous compound stewardship matter for R&D success?

Compound management in DMPK faces three major challenges: diverse container types, very large compound libraries, and strict storage-condition requirements. Automation depends on standardizing consumables. WuXi AppTec DMPK has developed a comprehensive compound lifecycle management system that integrates hardware, software, image-based recognition, automated handling, and systems integration to deliver automated, auditable, and scalable compound stewardship suitable for regulated and quality-conscious environments.

How do we enable real-time logistics tracking and full-process traceability?

We achieve full-process traceability through three core capabilities: realtime logistics synchronization, comprehensive lifecycle logging, and automated in-storage management via the Smart Compound Library.

1.Real-time package logistics and synchronized metadata

When a customer or third-party ships a package, our system initiates continuous monitoring based on the tracking number. Automated alerts are sent to designated receivers based on pick-up and transit milestones to ensure timely attention and safe, on-schedule delivery. Real-time logistics data are synchronized and stored in our system, compensating for delays inherent in querying third-party waybill histories, and enabling one-click traceability that links each specific compound to its parcel and live transit status. The system supports integration with third-party courier platforms via API to keep metadata synchronized and tamper-evident.

2.Full-process lifecycle management with tamper-evident logs

Our whole-process management records every timestamp from dispatch and sign-off to internal transfers and final return or disposal. The lifecycle is partitioned into three stages-pre-receipt, post-receipt, and return/disposal-with photographic capture on arrival to verify receipt time, automatic logging of intra-company transfers, and explicit time nodes for returns or destruction. All operational events (receipt photo capture, internal transfers, operators, timestamps) are preserved in tamper-evident logs to support chain-of-custody and traceability. Compound managers can access traceable logs of compound information and transfer history for internal review.

3.Smart compound library: accurate, efficient in-storage management

A.Fully automated intake and inventory

Simplified operations: no manual label scanning-place a rack on the temporary staging turntable to complete storage.
Simplified retrieval: operators add compound barcodes to a pick list; the system locates, picks, and delivers requested items to the staging area without prior knowledge of exact locations.
Automated inventory: image-based recognition and automated verification compare physical contents with database records and produce reconciliation records, enabling efficient, high-accuracy stock verification.
Traceability: all actions are logged with operator IDs and timestamps, preserving data integrity and traceability.

B.Image-based recognition for position and orientation detection

Extensive image-training establishes standard parameters for diverse tube types and well positions. When calculated parameters fall within predefined thresholds, the system confirms presence and returns coordinates and similarity metrics. Per-well recognition thresholds account for lighting and angle variability; multiple trained parameter sets support different tube specifications to increase robustness and accuracy.

C.Flexible gripping strategies for multiple container types (0.7-8 mL)

Rack barcodes identify rack types and dynamically select the appropriate gripping scheme (height, opening stroke, angle). Combining these parameters with digital imagery and recognition, the robotic system reliably grasps tubes across volumes from 0.7 to 8 mL, supporting high throughput while minimizing sample damage.

D.Temperature and humidity control and intelligent pressure protection

The smart library maintains controlled temperature and humidity conditions to protect sample integrity. Pressure sensors integrated into pick operations halt automation immediately if pressure exceeds safe thresholds, protecting tube integrity during tube-picking.

E. Mobile double-sided cabinets for high-density storage (~4×)

A movable dense-cabinet design preserves a working channel for robotic pick-and-place while maximizing storage density. Defragmentation routines further optimize rack utilization. The result is approximately fourfold storage capacity versus fixed-cabinet layouts in the same footprint-delivering meaningful space and cost efficiencies.

How secure and integrable is the system?

The system is designed to ensure data integrity, secure access, and to meet varying project throughput.

Tamper-evident recordkeeping: All lifecycle events (receipt photo capture, internal transfers, operator actions, timestamps) are recorded in immutable logs that support chain-of-custody and third-party review.
Access control and data protection: Role-based access control (RBAC), detailed operation logs, and encryption for data at rest and in transit protect sample metadata and operational records from unauthorized access.
Reliable audit support: The system provides detailed, automatically generated traceable logs regarding compound information and transfer history to support customer data transparency.

What business value and managed service options does WuXi AppTec DMPK offer?

WuXi AppTec DMPK delivers measurable operational and cost benefits through automation and high-density storage, and offers flexible managed-service models to meet diverse customer needs.

Space and cost efficiencies: Mobile dense-cabinet designs and defragmentation routines can increase effective storage density by roughly fourfold versus fixed-cabinet layouts, reducing lab footprint and associated overhead.
Labor and error reduction: Automated storage, retrieval, and image-based inventory reduce manual handling and human error, improving throughput and data consistency.
Full-process managed services: Offerings include sample receipt, secure storage, in-lab distribution, and return or destruction-available as full custodial services or tailored modules.

Conclusion

Digitalization and automation are reshaping laboratory operations. WuXi AppTec DMPK's end-to-end compound management and Smart Compound Library services seamlessly bridge front-end sample intake (including registration, structure confirmation, and QC) with back-end data and analysis workflows. We provide a one-stop solution featuring high-precision inventory management, automated retrieval and aliquoting, and real-time end-to-end traceability, ensuring data integrity and high-density storage efficiency.

This intelligent system not only significantly shortens compounds preparation turnaround times but also helps clients substantially reduce operational costs and compliance risks by eliminating manual errors and enhancing data transparency. Ultimately, it accelerates critical R&D decision-making, enabling faster, safer, and more cost-effective DMPK research.

With operations across Asia, Europe, and North America, we offer integrated, end-to-end services through our unique CRDMO (Contract Research, Development, and Manufacturing Organization) platform.

Email: wuxiconcierge@wuxiapptec.com

WuXi AppTec is a trusted partner and contributor to the pharmaceutical and life sciences industries, providing R&D and manufacturing services that help advance healthcare innovation. With operations across Asia, Europe, and North America, we offer integrated, end-to-end services through our unique CRDMO (Contract Research, Development, and Manufacturing Organization) platform. We are privileged to work alongside partners across 30+ countries, supporting their efforts to bring breakthrough treatments to patients. Guided by our vision that every drug can be made and every disease can be treated, we are committed to advancing breakthroughs for patients-one collaboration at a time.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Smart Compound Stewardship for DMPK: WuXi AppTec DMPK's Automated Compound Management with Full-Process Traceability here

News-ID: 4567706 • Views: …

More Releases from WuXi AppTec

Why CMC and Manufacturability Matter in Early Drug Discovery
Why CMC and Manufacturability Matter in Early Drug Discovery
Key Takeaways Early chemistry, manufacturing, and controls (CMC) assessment helps teams evaluate biological promise alongside developability and manufacturability. Assessing synthesis, formulation, analytical control, and scale-up before candidate selection can identify liabilities and guide further investigation while development options remain open. CRO/CDMO providers should be evaluated on how their scientific teams work together. Teams should examine whether findings from discovery chemistry, process chemistry, formulation, and analytical work inform decisions before candidate selection and…
How WuXi AppTec Advances Next Generation Medicines Through Integrated Formulation Development
How WuXi AppTec Advances Next Generation Medicines Through Integrated Formulatio …
Formulation helps drug developers address the practical barriers between a molecule and a medicine: how it dissolves, remains stable, and reaches the body in a usable form. WuXi AppTec (https://www.wuxiapptec.com/) brings this work together with chemistry and manufacturing, supporting development from the first formulation studies through late-stage supply. For complex molecules, these decisions have immediate consequences. Poor absorption can hold back an oral drug candidate even when it acts on its…
Which CRO Can Run DMPK Studies? Key Capabilities, Selection Criteria, and Case Examples
Which CRO Can Run DMPK Studies? Key Capabilities, Selection Criteria, and Case E …
Key Takeaways: A CRO's DMPK capabilities should match the program's development stage and scientific questions. Relevant services include in vitro ADME, in vivo pharmacokinetics, metabolite identification, and bioanalysis, with study selection guided by the decisions needed during discovery and IND-enabling development. Selecting a DMPK partner requires evaluating modality expertise, data quality, regulatory experience, and scientific integration. Fit-for-purpose assays and coordinated interpretation across chemistry, biology, bioanalysis, toxicology, and CMC help translate findings…
Automating Peptide Metabolite Identification: Realizing Speed and Precision with TidesID Platform by WuXi AppTec DMPK
Automating Peptide Metabolite Identification: Realizing Speed and Precision with …
Peptide drugs exhibit unparalleled advantages in targeting "undruggable" protein-protein interactions. However, unmodified peptides naturally suffer from poor physiological stability and are rapidly cleaved by endopeptidases and exopeptidases circulating within the liver, kidney, blood, and gastrointestinal barriers. To improve druggability, developers deploy cyclic architectures and non-natural amino acid modifications. Consequently, executing rigorous peptide metabolite identification (MetID) becomes a critical regulatory milestone to uncover vulnerabilities early, continuously optimize molecular structures, and assess…

All 5 Releases


More Releases for DMPK

Which CRO Can Run DMPK Studies? Key Capabilities, Selection Criteria, and Case E …
Key Takeaways: A CRO's DMPK capabilities should match the program's development stage and scientific questions. Relevant services include in vitro ADME, in vivo pharmacokinetics, metabolite identification, and bioanalysis, with study selection guided by the decisions needed during discovery and IND-enabling development. Selecting a DMPK partner requires evaluating modality expertise, data quality, regulatory experience, and scientific integration. Fit-for-purpose assays and coordinated interpretation across chemistry, biology, bioanalysis, toxicology, and CMC help translate findings…
Automating Peptide Metabolite Identification: Realizing Speed and Precision with …
Peptide drugs exhibit unparalleled advantages in targeting "undruggable" protein-protein interactions. However, unmodified peptides naturally suffer from poor physiological stability and are rapidly cleaved by endopeptidases and exopeptidases circulating within the liver, kidney, blood, and gastrointestinal barriers. To improve druggability, developers deploy cyclic architectures and non-natural amino acid modifications. Consequently, executing rigorous peptide metabolite identification (MetID) becomes a critical regulatory milestone to uncover vulnerabilities early, continuously optimize molecular structures, and assess…
Myotonic Dystrophy Clinical Trial Pipeline Analysis: 20+ Key Companies Shaping t …
DelveInsight's Myotonic Dystrophy Pipeline Insight 2026 report provides comprehensive global coverage of available and pipeline Myotonic Dystrophy therapies across various stages of clinical and nonclinical development. More than 20 companies are working to advance 22+ pipeline drugs, with pharmaceutical and biotechnology companies developing novel therapeutic approaches aimed at addressing the underlying genetic mechanisms and multisystem manifestations associated with Myotonic Dystrophy. Key takeaways from the Myotonic Dystrophy Clinical Trial Landscape Report • DelveInsight's Myotonic…
Which CRO Is Good at Protein Degradation? How WuXi AppTec Supports Integrated De …
Key Takeaways A suitable CRO for protein degradation should connect discovery biology, medicinal chemistry, drug metabolism and pharmacokinetics (DMPK), and development capabilities within one coordinated platform. WuXi AppTec(https://www.wuxiapptec.com/) supports targeted protein degrader programs with linked discovery technologies, chemistry expertise, and development support designed to scale as programs progress. As targeted protein degradation expands across oncology, immunology, and other disease areas, integrated execution can reduce delays, support better decisions, and help programs move toward…
How WuXi AppTec's Integrated CRDMO Model Supports Biotechnology Companies from D …
Key Takeaways Investigational New Drug (IND) submission requires coordinated decisions across biology, DMPK, bioanalysis, and chemistry, manufacturing, and controls (CMC). WuXi AppTec's (https://www.wuxiapptec.com/)integrated CRDMO (Contract Research, Development and Manufacturing Organization) model connects these functions from early discovery through IND submission. Case studies involving integrated drug metabolism and pharmacokinetics (DMPK) and toxicology, molecular-glues bioanalysis, siRNA-lipid conjugates, and expedited manufacturing illustrate how integration can address technical bottlenecks and improve development efficiency. For biotechnology companies,…
Which CRO Is Good at Protein Degradation?
Key Takeaways An idealCRO for protein degradation combines discovery biology, medicinal chemistry, drug metabolism and pharmacokinetics (DMPK), and development expertise within an integrated platform. WuXi AppTec helps innovators advance targeted protein degrader programs through coordinated discovery technologies, chemistry expertise, and scalable development support. As targeted protein degradation expands across oncology, immunology, and other disease areas, integrated partners can help reduce delays, improve decisions, and accelerate progression to clinic. Introduction Which CRO is good at protein…